Radioactive drug

Source: Childhood Gastrointestinal Neuroendocrine Tumors (PDQ®)–Patient Version, National Cancer Institute.

Source updated: May 7, 2025 · Captured 2026-09-09.

Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary. Independent clinical review is pending.

Context: Types of treatment for childhood gastrointestinal neuroendocrine tumor / Treatment options

A radioactive drug contains a radioactive substance and is used to diagnose or treat disease, including cancer. Lutetium Lu 177-dotatate is a radioactive drug used to treat gastrointestinal neuroendocrine tumor.

Preserved source evidence · Independent clinical review pending · Not medical advice